RxE2 Inc.

Amendment
CIK: 0001855833·Other·DELAWARE·Filed: Apr 19, 2021
Total Offering

$2,000,000

Amount Sold

$2,000,000

Investors

0

First Sale

Mar 31, 2021

Offering Details

Type
Equity, Other: Series Seed Preferred
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Gerald E. Finken
Related Person

Company

RxE2 Inc.

4302 13TH AVE S, STE. 4326

FARGO, ND, 58103

701-361-7650

SEC Filing

0001855833-21-000005

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
RxE2 Inc. Form D Filing — $2,000,000 | FilingFlow